PBM, CVS Health and Ed DeVaney

CVS Health names Ed DeVaney president of PBM business
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS Caremark taps Ed DeVaney as president of PBM business
DeVaney was named interim president of Caremark's PBM business in December 2024. CVS Health has named Ed DeVaney president of the company’s Caremark pharmacy benefit management business. Named interim president in December 2024, he will report to Prem Shah, group president of CVS Health.
CVS Health names DeVaney as President of CVS Caremark
CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president
CVS names PBM president
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS Health.
Modern Healthcare2d
FTC's insulin case against UnitedHealth, CVS, Cigna PBMs advances
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
FTC case against Caremark, Express Scripts, Optum Rx can move forward, judge rules
A Missouri district court judge on Tuesday said stopping the FTC’s suit against the Big Three PBMs would be “against the ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
pharmaphorum3d
FTC doubles down on PBM criticism in new report
the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx. It concludes that the PBMs generated $7.3 billion by marking up drugs in these ...
Reuters1mon
Oklahoma takes CVS Caremark to new PBM court over alleged underpayments
Jan 23 (Reuters) - Oklahoma's attorney general has accused CVS's (CVS.N ... the three largest PBMs - Caremark, UnitedHealth Group's Optum, and Cigna's Express Scripts - netted $7.3 billion ...